acebutolol and Generalized Resistance To 1,25-Dihydroxyvitamin D

acebutolol has been researched along with Generalized Resistance To 1,25-Dihydroxyvitamin D in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Schaefer, B; Wolf, M; Zoller, H1
Edmonston, D; Wolf, M1

Reviews

1 review(s) available for acebutolol and Generalized Resistance To 1,25-Dihydroxyvitamin D

ArticleYear
FGF23 at the crossroads of phosphate, iron economy and erythropoiesis.
    Nature reviews. Nephrology, 2020, Volume: 16, Issue:1

    Topics: Anemia, Iron-Deficiency; Bone and Bones; Calcium; Erythropoiesis; Familial Hypophosphatemic Rickets; Ferric Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hypophosphatemia; Inflammation; Iron; Maltose; Phosphates; Protein Processing, Post-Translational; Renal Insufficiency, Chronic; RNA, Messenger; Transcription, Genetic

2020

Other Studies

1 other study(ies) available for acebutolol and Generalized Resistance To 1,25-Dihydroxyvitamin D

ArticleYear
Risk Factors for and Effects of Persistent and Severe Hypophosphatemia Following Ferric Carboxymaltose.
    The Journal of clinical endocrinology and metabolism, 2022, 03-24, Volume: 107, Issue:4

    Topics: Alkaline Phosphatase; Anemia, Iron-Deficiency; Biomarkers; Calcium; Disaccharides; Familial Hypophosphatemic Rickets; Female; Ferric Compounds; Humans; Hypophosphatemia; Iron; Male; Maltose; Minerals; Osteomalacia; Parathyroid Hormone; Risk Factors

2022